* Says U.S. FDA approved nucleus implants for magnetic resonance imaging use up to 3.0T with magnet removed 登録するここ. * Additionally, with use of cochlear nucleus implant bandage and splint kit, nucleus ...

Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® ...

Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System – the world’s first and only, ...

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

[画像1: https://prtimes.jp/i/79047/42/resize/d79047-42-277c0f5ae9068047b46e-0.jpg] 人工内⽿システムのパイオニア・豪コクレア社の日本法人 ...

LONE TREE, Colo., Feb. 25, 2025 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic ...

The near-$18bn group is now guiding to an underlying net profit of between $390m and $400m, comparing to its FY24 result of $386.6m. At the time of its first-half results release in February, Cochlear ...

Investing.com - Canaccord Genuity upgraded Cochlear Ltd. (ASX:COH) from Hold to Buy and set a price target of AUD330.00, citing strong device demand and promising technology developments. The hearing ...